323990 — VaxCell Biotherapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩186bn
- KR₩163bn
- KR₩7bn
Annual cashflow statement for VaxCell Biotherapeutics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4,763 | -6,825 | -10,274 | -10,624 | -13,340 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 270 | 291 | -127 | -1,449 | 784 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -427 | 178 | 578 | -91.6 | -253 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4,662 | -6,045 | -9,423 | -10,699 | -10,627 |
| Capital Expenditures | -2,228 | -290 | -199 | -4,065 | -6,779 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,009 | 4,624 | -51,588 | 14,388 | 17,156 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,237 | 4,333 | -51,787 | 10,322 | 10,377 |
| Financing Cash Flow Items | -86.8 | — | -1,174 | 0.339 | -0.829 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 305 | -208 | 69,866 | -849 | -1,348 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7,594 | -1,919 | 8,657 | -1,225 | -1,598 |